Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

13.51

-0.49 (-3.50%)

At close: Feb 20, 2026, 4:00 PM EST

13.65

+0.14 (1.04%)

After-hours: Feb 20, 2026, 5:21 PM EST

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	392	256	220	235	1,075	1,148
Market Cap Growth	264.70%	16.57%	-6.67%	-78.12%	-6.39%	24.98%
Enterprise Value	343	259	173	73	809	784
Last Close Price	13.51	11.97	10.36	11.17	51.87	56.81
PS Ratio	5.85	3.92	3.25	2.97	12.48	11.83
PB Ratio	3.10	3.95	1.70	1.09	3.35	2.88
P/TBV Ratio	3.10	3.95	1.70	1.09	3.35	2.88
EV/Sales Ratio	5.13	3.96	2.56	0.93	9.39	8.08
Debt / Equity Ratio	1.53	3.11	1.76	1.03	0.08	0.02
Net Debt / Equity Ratio	-0.38	0.19	-0.17	-0.68	-0.78	-0.86
Net Debt / EBITDA Ratio	0.72	-0.15	0.19	1.09	2.08	3.25
Net Debt / FCF Ratio	2.64	-0.38	0.23	1.31	2.90	4.89
Asset Turnover	0.20	0.20	0.16	0.19	0.21	0.21
Quick Ratio	4.35	4.03	4.99	6.52	10.00	8.43
Current Ratio	4.44	4.21	5.21	6.73	10.45	8.82
Return on Equity (ROE)	-60.01%	-84.63%	-67.16%	-49.74%	-33.78%	-18.48%
Return on Assets (ROA)	-13.47%	-16.23%	-18.13%	-20.47%	-19.01%	-14.81%
Return on Invested Capital (ROIC)	-69.31%	-92.97%	-138.32%	-163.29%	-94.88%	-91.02%
Return on Capital Employed (ROCE)	-25.70%	-36.80%	-38.10%	-34.30%	-35.80%	-27.20%
Earnings Yield	-18.25%	-32.00%	-52.86%	-56.90%	-11.33%	-6.88%
FCF Yield	-4.71%	-12.57%	-44.06%	-47.71%	-8.08%	-6.16%
Buyback Yield / Dilution	-9.53%	-0.85%	-0.90%	-1.78%	-2.14%	-1.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q